<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="50223">Dexrazoxane</z:chebi> (DEX), an inhibitor of topoisomerase II and intracellular iron <z:chebi fb="0" ids="38161">chelator</z:chebi>, is believed to reduce the formation of reactive oxygen species (ROS) and protects the heart from the toxicity of <z:chebi fb="0" ids="48120">anthracycline</z:chebi> <z:chebi fb="0" ids="35610">antineoplastics</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>As ROS also play a role in the pathogenesis of <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">cardiac ischaemia</z:e>/reperfusion (I/R) injury, the aim was to find out whether DEX can improve cardiac ischaemic tolerance </plain></SENT>
<SENT sid="2" pm="."><plain>DEX in a dose of 50, 150, or 450 mg·(kg body mass)(-1) was administered intravenously to rats 60 min before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Myocardial <z:mpath ids='MPATH_124'>infarct</z:mpath> size and <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> were assessed in anaesthetized open-chest animals subjected to 20 min coronary <z:mp ids='MP_0006134'>artery occlusion</z:mp> and 3 h reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0011675'>Arrhythmias</z:hpo> induced by I/R were also assessed in isolated perfused hearts </plain></SENT>
<SENT sid="5" pm="."><plain>Only the highest dose of DEX significantly reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> size from 53.9% ± 4.7% of the area at risk in controls to 37.5% ± 4.3% without affecting the myocardial markers of <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>On the other hand, the significant protective effect against reperfusion <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> occurred only in perfused hearts with the dose of DEX of 150 mg·kg(-1), which also tended to limit the incidence of ischaemic <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>It is concluded that DEX in a narrow dose range can suppress <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> in isolated hearts subjected to I/R, while a higher dose is needed to limit myocardial <z:mpath ids='MPATH_124'>infarct</z:mpath> size in open-chest rats </plain></SENT>
</text></document>